Cookies help us improve your website experience.
By using our website, you agree to our use of cookies.
    • Protect the environment. Think before you print.

Do you have a strong opioid program for your injured employees?

June 9, 2016

Overuse of drugs, coupled with workers’ compensation claims, may lead to increased medical costs.

Dr. Joseph Semkiu

National Medical Director

Dr. Joe Semkiu joined Zurich in December, 2007. As Zurich's United States' Medical Director, his... About this expert

medical vials

Per the Centers for Disease Control and Prevention (CDC), 78 Americans die every day from an opioid overdose. In 2014, more people died from drug overdoses than in any year on record, with the majority of those deaths (more than six out of ten) involving an opioid.

Do you have a strong opioid program for your injured employees?

Drugs prescribed to address pain related to worker injuries can include narcotics – chemical substances often associated with physical dependence and psychological addiction. Prescription narcotics, in some instances, may escalate toward negative medical consequences, such as addiction, illicit drug use or non-medical use. Drug over-utilization coupled with workers’ compensation claims may lead to increased medical costs, higher risk of surgery, prolonged opioid use, increased days away from work and accidental opioid overdose.

As discussed in my recent article, "Opioid Abuse: The Undetected Risk in Your Organization" (co-authored with Eric Lambert) for FMI Quarterly, a recent Mayo Clinic study found one in four patients prescribed an opioid painkiller for the first time progressed to long-term prescriptions.

A strong opioid pharmacy program, focusing on patient safety and addressing escalating claims costs, is an important part of patient care. It assists claims professionals in identifying red flags related to opioid use and provides the proper medical oversight when red flags are present. These programs usually include nurse case managers and peer review involvement to help identify prescribing patterns or behaviors that lead to negative medical consequences. After a review of medical outcomes for claims referred into Zurich’s program, we have seen a reduction in cases involving multiple prescribers, multiple pharmacies and injured workers receiving a higher dose of narcotics than necessary.

Because of the potential risks, the standards of care for physicians who prescribe narcotics in the management of chronic pain include both drug screening and drug agreements.

Drug screening

Employment-related drug testing falls into four categories: post offer, random, post-accident and “for cause.” It is the random drug screening that is the standard of care when narcotics have been prescribed. The purposes of a random urine drug test in this circumstance include:

  • Verifying the person is taking the medications as prescribed — not diverting or selling the drugs
  • Ruling out the presence of illicit, illegal drugs

Drug testing only identifies the presence of substances; however drug screen panels (other than those mandated by state and federal agencies) can be customized for drugs used.

Drug agreement

Signed by the patient prescribed narcotics and the prescribing physician, a drug agreement outlines the responsibilities of the patient being prescribed drugs. These responsibilities include submission to random, unannounced drug testing to verify compliance with prescribed pain regimens and verification that there are no illicit or illegal drugs being taken. Consequences for failure to comply with the drug agreement can include discontinuance of the pain medication and termination from the physician’s practice.

Related Articles